Search

Author/Creator Xiong, Kuangnan

1. Impact of natalizumab on quality of life in a real-world cohort of patients with multiple sclerosis: Results from MS PATHS. Issue 2 (April 2021)

Authors:
Hersh, Carrie M; Kieseier, Bernd; Moor, Carl de; Miller, Deborah M; Campagnolo, Denise; Williams, James R; Fitzgerald, Kathryn C; Xiong, Kuangnan; McGinley, Marisa P; Hyland, Megan; Rudick, Richard A; Ziemssen, Tjalf; Koulinska, Irene
Journal:
Multiple sclerosis journal, experimental, translational and clinical
Issue:
Volume 7:Issue 2(2021)
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

3. Serum neurofilament light levels in natalizumab-treated patients with multiple sclerosis who switch to extended interval dosing from every-4-week dosing in real-world clinical practice. (February 2023)

Authors:
Foley, John; Xiong, Kuangnan; Hoyt, Tammy; Singh, Carol M; Riddle, Evan; de Moor, Carl; Plavina, Tatiana; Campbell, Nolan
Journal:
Multiple sclerosis
Issue:
Volume 29:Number 2(2023)
Page Start:
196
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗